Letero is a prescription medication used to treat certain types of breast cancer, including hormone-receptor-positive breast cancer.
Composition:
Each tablet of Letero contains 2.5mg of letrozole.
Mechanism of Action:
Letrozole works by:
- Reducing the production of estrogen in the body, which can help slow or stop the growth of breast cancer cells
- Inhibiting the activity of estrogen receptors, which can help prevent cancer cells from growing and multiplying
Uses:
Letero is used to treat:
- Postmenopausal women with hormone-receptor-positive advanced breast cancer
- Postmenopausal women with early breast cancer who have undergone surgery and are at high risk of recurrence
Dosage:
The recommended dosage of Letero is:
- 2.5mg taken orally once daily, starting on the first day of a menstrual cycle
Side Effects:
Common side effects of Letero include:
- Hot flashes
- Joint pain
- Muscle pain
- Fatigue
- Headache
- Nausea and vomiting
- Increased risk of osteoporosis
- Increased risk of bone fractures
Recommendation:
Letero is recommended for postmenopausal women who have hormone-receptor-positive breast cancer. Patients should also be advised to monitor their blood counts and liver function regularly during treatment.
Important Note:
Patients should not take Letero if they have a history of severe allergic reactions, kidney problems, or liver problems. Patients should also inform their healthcare provider if they have any underlying medical conditions, such as heart problems or lung problems, before taking Letero.
Some common brands of letrozole include:
- Femara (Novartis)
- Letrozole (Novartis)
Please note that Letero is not available in all markets and may be approved for different indications and dosages in different regions.
Reviews
There are no reviews yet.